Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Forensic Medicine and Pathology

Volume  12, Issue 3, July-September 2019, Pages 195-199
 

Original Article

Clinical Profile of the Patients with Antiphospholipid Antibodies: Lupus Anticoagulant and Anticardiolipin Antibodies

Kanika Deora1, Ruchee Khanna

1Intern, 2Associate Professor, Department of Pathology, Kasturba Medical College, Manipal, 576104, India.

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijfmp.0974.3383.12319.6

Abstract

A retrospective analysis of clinical profile of the patients positive for antiphospholipid antibodies (150) that are lupus anticoagulant (83) and anticardiolipin antibodies (57) was carried out from January 2015 to December 2016 in Kasturba Medical College, Manipal. The diagnosis of lupus anticoagulants was based on prolongation of dRVVT, its absence of correction with normal plasma and correction by phospholipids. The presence of antiardiolipin antibodies was based on the technique ELISA (uolmmun). Out of 150 patients positive for antiphospholipid antibodies, the mean age of presentation was 38 years, more commonly seen in the women. The frequency of thrombosis in patients positive for lupus anticoagulants was 55.5% (46), more commonly of venous origin and in the lower limbs. The frequency of patients with lupus anticoagulants presenting with abortion was 26 (31.3%), immune thrombocytopenic purpura, was 80% (67), valvular heart disease was 5 (6%), 35 (42.1%) patients had secondary LA due to autoimmune diseases like SLE, Sjogerns, APS. Anticardiolipin antibodies were present in 57 patients, more common in women. Thrombosis was seen in 28 (49%) patients, more of venous origin and in the lower limbs. Other clinical manifestations were abortions seen in 8 (9%) patients, immune thrombocytopenic purpura seen in 18 (32.5%) patients, valvular heart diseases seen in 8 (14%) of the patients and autoimmune diseases seen in 31.3% of the patients. Patients positive for both lupus anticoagulant and anticardiolipin antibodies (10) had a higher rate of thrombosis around 60%, more commonly of venous origin and had higher associations with autoimmune diseases (80%).

Keywords: Lupus anticoagulants; Anticardiolipin antibodies; SLE.


Corresponding Author : Kanika Deora